Quantbot Technologies LP Eagle Pharmaceuticals, Inc. Transaction History

Quantbot Technologies LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$4.26 - $6.51 $8,520 - $13,020	-2,000 Reduced 62.5%	1,200 $6,000
Q4 2023 Feb 14, 2024	BUY	$4.63 - $15.21 $3,704 - $12,168	800 Added 33.33%	3,200 $16,000
Q3 2023 Nov 07, 2023	SELL	$15.21 - $22.88 $41,067 - $61,776	-2,700 Reduced 52.94%	2,400 $37,000
Q2 2023 Aug 08, 2023	BUY	$17.74 - $31.87 $762 - $1,370	43 Added 0.85%	5,100 $99,000
Q1 2023 May 12, 2023	BUY	$25.06 - $34.09 $126,728 - $172,393	5,057 New	5,057 $143,000
Q3 2022 Nov 07, 2022	BUY	$26.42 - $47.12 $44,914 - $80,104	1,700 New	1,700 $44,000
Q4 2020 Feb 12, 2021	SELL	$41.72 - $51.34 $9,387 - $11,551	-225 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$37.02 - $51.28 $8,329 - $11,538	225 New	225 $9,000
Q3 2018 Nov 13, 2018	SELL	$66.65 - $83.86 $8,597 - $10,817	-129 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$51.25 - $76.62 $6,611 - $9,883	129 New	129 $9,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.